Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid Carcinomas-Reference-Cited by-同舟云学术

Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid Carcinomas

Published:2004-02 Issue:1 Volume:19 Page:65-71
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Bodei Lisa¹,Handkiewicz-Junak Daria¹,Grana Chiara¹,Mazzetta Chiara²,Rocca Paola¹,Bartolomei Mirco¹,Lopera Sierra Maribel¹,Cremonesi Marta³,Chinol Marco¹,Mäcke Helmut R.⁴,Paganelli Giovanni¹

Affiliation:

1. Nuclear Medicine Division, European Institute of Oncology, Milan, Italy

2. Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

3. Medical Physics Division, European Institute of Oncology, Milan, Italy

4. Division of Radiological Chemistry, University Hospital, Basel, Switzerland

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497804773391694

Reference27 articles.

1. Long term follow-up of patients with medullary carcinoma of the thyroid

2. Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables

3. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: A retrospective study of 109 consecutive patients

4. Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local Control

5. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin and Somatostatin Receptors in Tumour Biology;International Journal of Molecular Sciences;2023-12-28

2. Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma;Annales d'Endocrinologie;2023-02

3. Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer;Clinical Nuclear Medicine;2023-01-12

4. Medullary Thyroid Carcinoma presenting as an Incidentaloma on Gallium-68-PSMA-PET/CT – Systematic Literature Review and Case Report;Nuklearmedizin - NuclearMedicine;2022-08-11

5. Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors;Hormone and Metabolic Research;2022-07-25